Critical Path Institute is offering an exciting new opportunity for pharmacometricians. A new consortium focusing on quantitative drug development platforms for Huntington's disease is looking for a talented modeling and simulation scientist. This represents a great opportunity for intellectual and personal growth with a positive impact on public health, in a collaborative effort that allows the opportunity to interact with leading academics, industry scientists, and regulators. For more information, please check https://c-path.org/wp-content/uploads/2016/09/AssociateProgramDirectorQuantitativeMedicine.pdf or contact h...@c-path.org.
-- Daniela J Conrado, MS PhD Associate Director, Quantitative Medicine Critical Path Institute
